Living Donor Liver Transplant for Colorectal Liver Metastases
This study is looking at living donor liver transplantation (LDLT) for people with colorectal cancer that has spread to the liver (metastatic colorectal cancer) and cannot be removed by surgery. The study aims to collect information on patients who undergo this procedure to understand how well they do. Researchers will track how many patients are still alive and free from cancer recurrence after 5 years. You may be able to join if you are 18 or older, have colorectal cancer that has spread to the liver and cannot be cured by surgery, and are considered a candidate for LDLT by the University of Rochester liver transplant program. The current recruitment status is unclear.
- Study design
- This is an observational study that plans to enroll 25 participants. It is designed to collect data on patients undergoing living donor liver transplantation.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed to measure recurrence-free survival and overall survival at 5 years after the transplant.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Roberto Hernandez-Alejandro, MD · PRINCIPAL_INVESTIGATOR · University of Rochester
- Matthew Byrne, MD · STUDY_DIRECTOR · University of Rochester
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- percentage of patients with recurrence free survival5 years
RFS proportions to be calculated at 1, 3, and 5 years with Kaplan Meier analysis
- percentage overall survival5 years
OS proportions to be calculated at 1, 3, and 5 years with Kaplan Meier analysis